Home›Companies›Healthcare›Supira Medical

Supira Medical, Inc.

Updated Oct 29, 2026·Latest SEC filing Apr 3, 2025·Suggest an edit

About Supira Medical

Supira Medical is a private company based in Campbell, California. It has reported $220,686,792 raised in six offerings on Form D since December 2017. Its chief executive is Nitin Salunke.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 25, 2025Apr 3, 2025$119,999,984fully sold20$5.9MEquityRule 506(b)Form D ↗
Nov 17, 2023Dec 1, 2023$21,086,842of $39.9M target22$958KEquityRule 506(b)Form D ↗
Feb 25, 2022Mar 10, 2022$29,999,980of $30.0M target31$967KEquityRule 506(b)Form D ↗
Feb 25, 2020Mar 11, 2020$35,099,991fully sold31$1.1MEquityRule 506(b)Form D ↗
Apr 25, 2018May 15, 2018$12,884,997fully sold24$536KEquityRule 506(b)Form D ↗
Dec 7, 2017Dec 22, 2017$1,614,998of $2.0M target15$107KEquityRule 506(b)Form D ↗
Total, six offerings$220,686,792

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Supira Medical's Form D filed Apr 3, 2025.

NS
Nitin Salunke
President and Chief Executive Officer, director
CG
Casey Gordon
Director
Also a director at Laza Medical.
AS
Amr Salahieh
Director
Also a director at Adona Medical and a chief executive officer and director at Akura Medical and Laza Medical.

Earlier filings also listed Mariam Maghribi (executive officer, last listed May 2018) and Jean Orth (president and ceo, director, last listed May 2018).

Sources

  1. SECSupira Medical, Inc. filing history